Lifesciences Equipment Leasing Market In US size is set to grow by USD 685.99 mn from 2024-2028, Agilent Technologies Inc., American Capital Group Inc. & Avtech Financial Group of companies, and more to emerge as Some of the Key Vendors, Technavio

NEW YORK, March 25, 2024 /PRNewswire/ -- The global lifesciences equipment leasing market in us size is estimated to grow by USD 685.99 mn from 2024 to 2028, according to Technavio. The market is estimated to grow at a CAGR of 7.7% during the forecast period. North America held the largest share of the global market in 2023, and the market in the region is estimated to witness an incremental growth of 100%.

To understand more about this market- Download a FREE Sample Report in minutes!

Major Players in the Market

Numerous companies are capitalizing on this growing trend by implementing strategic measures such as alliances, partnerships, mergers, and acquisitions. Among the notable players in the cheese based snacks market are:

Agilent Technologies Inc., American Capital Group Inc., Avtech Financial Group of companies, Commercial Finance and Leasing Cardiff Bank Inc., Crestmont Capital LLC, CSC Leasing Co., Danaher Corp., Excedr Inc., GeNESIS Commercial Capital, GenTech Scientific LLC, Olympus Corp., Peoples Bancorp Inc., Rabobank Group, Royal Bank of Canada, Scientific Equipment Source Inc., Siemens AG, STINSON LLP, Sun South Equipment Leasing Inc., Thermo Fisher Scientific Inc., Waters Corp.

Key Market Drivers

The Lifesciences Equipment Leasing Market in the US is a strategic response for educational institutions, labs, and medical facilities seeking to acquire advanced laboratory instruments and medical devices without substantial upfront capital costs. With the high expense of lifesciences equipment, particularly the latest models, leasing enables better financial planning and resource allocation. This solution facilitates the spread of costs over time through manageable lease payments, allowing organizations to allocate their valuable capital towards research funding, personnel hiring, or facility upgrades. The unpredictable nature of research and healthcare projects necessitates budget flexibility, making leasing an essential tool in the lifesciences sector.

Challenges and Opportunities

The Lifesciences Equipment Leasing Market in the US is a significant solution for budget-constrained research institutions. With the high cost of advanced equipment, leasing enables these institutions to access essential tools without a substantial upfront investment. Leasing breaks down the expense into manageable monthly payments, allowing for better financial planning. This approach frees up limited budgets for other research expenses, such as personnel costs and consumables. Leasing also provides flexibility, enabling institutions to acquire equipment for specific projects or temporary applications without long-term financial obligations.

The Lifesciences Equipment Leasing Market in the US is a vital solution for institutions seeking to remain competitive in the rapidly evolving field. With technology advancing at a swift pace, leasing enables organizations to upgrade equipment regularly without the financial burden of ownership. The shorter lifecycles of lifesciences equipment, often resulting from technological obsolescence, necessitate more frequent upgrades and replacements. Leasing mitigates the risk of investing in outdated equipment and provides the flexibility to adapt to emerging technologies seamlessly. This market is essential for research and healthcare institutions, ensuring they have access to the latest tools and innovations.

To understand more about this market- Download a FREE Sample Report in minutes!

Market Overview

The Lifesciences Equipment Leasing Market in the US is experiencing significant growth, driven by the increasing demand for advanced technological equipment in research and development sectors. According to recent reports, the market is expected to expand at a CAGR of over 10% during the forecast period. Companies such as Caterpillar Financial, GE Capital, and Compass Financial are major players in this market, offering flexible financing solutions for various types of lifesciences equipment. These leasing companies provide a range of services, including asset management, equipment installation, and maintenance. The use of digital technologies and IoT in equipment monitoring and management is also gaining popularity in the market. Additionally, the growing trend of outsourcing research and development activities is expected to fuel the demand for leasing services in the US lifesciences industry. Overall, the Lifesciences Equipment Leasing Market in the US presents a lucrative opportunity for investors and leasing companies alike.

Table of Contents:

 1 Executive Summary
 2 Market Landscape
 3 Market Sizing
 4 Historic Market Size
 5 Five Forces Analysis
 6 Market Segmentation
 7 Customer Landscape
 8 Geographic Landscape
 9 Drivers, Challenges, and Trends
10 Venodr Landscape
11 Vendor Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio